Ticker name:MIRAMIRA PHARMACEUTICALS, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.

Market Cap 39M

Last close 0.92$

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.1T1146.9$
2JNJJOHNSON & JOHNSON599B248.82$
3ABBVAbbVie Inc.448B253.38$
4MRKMerck & Co., Inc.307B124.4$
5NVSNOVARTIS AG285B149.56$
6AZNASTRAZENECA PLC255B164.52$
7AMGNAMGEN INC197B364.17$
8GILDGILEAD SCIENCES, INC.165B133.21$
9PFEPFIZER INC141B24.75$
10BMYBRISTOL MYERS SQUIBB CO123B60.16$
11SNYSanofi107B43.98$
12ZTSZoetis Inc.32B76.2$
13BIIBBIOGEN INC.30B199.95$
14OGNOrganon & Co.3.5B13.49$
15SCLXScilex Holding Co65M7.64$
16CTORCITIUS ONCOLOGY, INC.53M0.57$
17SRXHSRX Global Inc.42M2.17$
18MIRAMIRA PHARMACEUTICALS, INC.39M0.92$